Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05955170
Title Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer (TUC-TOC)
Acronym TUC-TOC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Curie
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Jean Perrin SUSPENDED Clermont-Ferrand Clermont Ferrand 63011 France Details
CHU Amiens Picardie-Site Sud NOT_YET_RECRUITING Amiens 80054 France Details
Institut Sainte Catherine RECRUITING Avignon 84000 France Details
Centre François Baclesse RECRUITING Caen 14076 France Details
Centre Georges-François Leclerc RECRUITING Dijon 21079 France Details
Centre Oscar Lambret NOT_YET_RECRUITING Lille 59020 France Details
Institut Du Cancer Montpellier SUSPENDED Montpellier 34298 France Details
Hôpital Privé du Confluent RECRUITING Nantes 44277 France Details
Institut Curie NOT_YET_RECRUITING Paris 75005 France Details
Hopital Saint-Louis Ap-Hp Senopole NOT_YET_RECRUITING Paris 75010 France Details
Centre CARIO-Hôpital Privé des Côtes d'Armor (HPCA) NOT_YET_RECRUITING Plerin 22190 France Details
Institut Curie RECRUITING Saint Cloud 92210 France Details
Oncopole Claudius Regaud SUSPENDED Toulouse 31059 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field